Skip to main content
ConductScienceScienceDex

Annelyn Torres-reveron

NIH Rank #13072
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11481175Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2025 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$1.2M
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#13,072
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Annelyn Torres-reveron. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Annelyn Torres-reveron as a PI. Multi-PI records show the full award amount for context.

  • 2R44HD109055-02A1R44
    Phase II- Repurposing CRH antagonists for the treatment of endometriosis
    Sur180 Therapeutics, Llc
    $1.2M
    award amount

Award organization

Organizations that administered FY2025 awards listing Annelyn Torres-reveron as a PI.

FY2025 award administered by Sur180 Therapeutics, Llc (TX).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    Sur180 Therapeutics, Llc
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2026
    $2M Cumulative Funding
  5. 2026
    Entered Top 50% Nationally
    Ranked #8149

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Annelyn Torres-reveron.

Caroline B Appleyard
Sur180 Therapeutics, Llc
2
shared awards

Explore further

Find collaborators for Annelyn Torres-reveron

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →